Source link : https://newshealth.biz/health-news/long-term-control-of-nmosd-with-ravulizumab/
For neuromyelitis optica spectrum disorder, long-term follow-up with a second-generation complement inhibitor shows an unprecedented level of disease control at 3 years. Medscape Medical News Source link : https://www.medscape.com/viewarticle/long-term-control-neuromyelitis-optica-spectrum-disorder-2025a1000qk8?src=rss Author : Publish date : 2025-10-03 07:58:00 Copyright for syndicated content belongs to the linked Source.
The post Long-Term Control of NMOSD With Ravulizumab first appeared on News Health.
—-
Author : News Health
Publish date : 2025-10-03 07:58:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8